We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
-0.38%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
-$11.3M
Cap. Flow
-$9.53M
Cap. Flow %
-7.77%
Top 10 Hldgs %
32.22%
Holding
85
New
3
Increased
33
Reduced
32
Closed
10

Top Buys

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$3.29M
2
GEV icon
GE Vernova
GEV
+$498K
3
THS
Treehouse Foods
THS
+$380K
4
INTC icon
Intel
INTC
+$377K
5
SLB icon
SLB Ltd
SLB
+$99.1K

Top Sells

Rank Stock Value
1
KR icon
Kroger
KR
+$3.47M
2
SO icon
Southern Company
SO
+$1.85M
3
CVX icon
Chevron
CVX
+$1.56M
4
DE icon
Deere & Co
DE
+$1.01M
5
MRK icon
Merck
MRK
+$928K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.63%
2 Technology 16.72%
3 Healthcare 14.21%
4 Energy 11.43%
5 Materials 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTR icon
26
Nutrien
NTR
$32.4B
$2.88M 2.35%
56,641
+216
+0.4% +$11.8K
INTC icon
27
Intel
INTC
$462B
$2.79M 2.28%
90,114
+11,496
+15% +$377K
JNJ icon
28
Johnson & Johnson
JNJ
$641B
$2.79M 2.27%
19,063
+189
+1% +$28.1K
CVX icon
29
Chevron
CVX
$378B
$2.77M 2.26%
17,703
-9,774
-36% -$1.56M
BMY icon
30
Bristol-Myers Squibb
BMY
$128B
$2.5M 2.04%
60,313
+1,249
+2% +$55.9K
GLD icon
31
SPDR Gold Trust
GLD
$132B
$1.1M 0.9%
5,135
-32
-0.6% -$6.92K
ZBRA icon
32
Zebra Technologies
ZBRA
$12.6B
$855K 0.7%
2,767
+49
+2% +$14.9K
SMG icon
33
ScottsMiracle-Gro
SMG
$4.06B
$842K 0.69%
12,940
-111
-0.9% -$7.59K
CTVA icon
34
Corteva
CTVA
$58.6B
$837K 0.68%
15,519
+882
+6% +$48.6K
HAE icon
35
Haemonetics
HAE
$3.63B
$817K 0.67%
9,876
-123
-1% -$10.8K
BILZ icon
36
PIMCO Ultra Short Government Active ETF
BILZ
$1B
$793K 0.65%
7,845
-3,995
-34% -$403K
SCHW
37
Charles Schwab
SCHW
$181B
$642K 0.52%
8,711
+81
+0.9% +$5.98K
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$3.99T
$620K 0.51%
3,406
-49
-1% -$8.26K
JPM icon
39
JPMorgan Chase
JPM
$947B
$615K 0.5%
3,041
-105
-3% -$20.5K
KEX icon
40
Kirby Corp
KEX
$7.76B
$578K 0.47%
4,829
-1,079
-18% -$121K
OXY icon
41
Occidental Petroleum
OXY
$54.6B
$540K 0.44%
8,572
+777
+10% +$49.8K
GEV icon
42
GE Vernova
GEV
$265B
$539K 0.44%
+3,140
New +$498K
MTRX icon
43
Matrix Service
MTRX
$347M
$537K 0.44%
54,055
+2,206
+4% +$25.2K
CFR icon
44
Cullen/Frost Bankers
CFR
$10.3B
$523K 0.43%
5,151
-1,005
-16% -$105K
HD icon
45
Home Depot
HD
$335B
$522K 0.43%
1,516
+69
+5% +$23.5K
VGSH icon
46
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$479K 0.39%
8,262
-20
-0.2% -$1.16K
RVTY icon
47
Revvity
RVTY
$12.1B
$477K 0.39%
4,553
+678
+17% +$72K
ERII icon
48
Energy Recovery
ERII
$439M
$460K 0.38%
34,615
+4,665
+16% +$64.3K
AAPL icon
49
Apple
AAPL
$4.95T
$448K 0.37%
2,125
-131
-6% -$24.4K
MINT icon
50
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$426K 0.35%
4,230

Similar funds

Keene & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Keene & Associates held 85 positions worth $123M, down 8.4% from $134M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Keene & Associates withdrew a net $9.53M in Q2 2024, closing 10 positions and reducing 32 holdings. Its most notable exit was Kroger, an estimated $3.47M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Keene & Associates opened a new position in Kinder Morgan worth $3.43M.

  • Keene & Associates's largest Q2 2024 buy was Kinder Morgan: 172,775 shares worth $3.43M.
  • Keene & Associates added most to Intel in Q2 2024, an estimated $377K increase.
  • Keene & Associates's biggest Q2 2024 reduction was Chevron, cutting an estimated $1.56M.
  • Keene & Associates fully exited Kroger in Q2 2024, selling an estimated $3.47M.
  • Keene & Associates's ten largest holdings make up 32% of its $123M portfolio in Q2 2024.
  • Keene & Associates opened 3 new positions and closed 10 in Q2 2024.
  • Keene & Associates's portfolio value fell 8.4% quarter-over-quarter to $123M.

Based on Keene & Associates's 13F filing for Q2 2024, filed 9 Aug 2024.